NASDAQ · ARAY
Healthcare · Medical - Devices
$0.25
Down-$0.01 (-2.84%)
Updated Sep 10, 2026, 11:50 PM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
ARAY closed at $0.25 after 20 trading sessions, down 10.68% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 9, 2026 | $0.262 | $0.2638 | $0.25 | $0.2501 | 359.58K |
| Sep 8, 2026 | $0.266 | $0.2822 | $0.2601 | $0.262 | 433.72K |
| Sep 4, 2026 | $0.266 | $0.2722 | $0.2547 | $0.2668 | 291.81K |
| Sep 3, 2026 | $0.2648 | $0.2695 | $0.2601 | $0.266 | 247.97K |
| Sep 2, 2026 | $0.251 | $0.2612 | $0.25 | $0.26 | 323.8K |
| Sep 1, 2026 | $0.261 | $0.2642 | $0.2524 | $0.2546 | 550.69K |
| Aug 31, 2026 | $0.27 | $0.2754 | $0.2612 | $0.263 | 242.49K |
| Aug 28, 2026 | $0.261 | $0.2838 | $0.26 | $0.2739 | 643.58K |
| Aug 27, 2026 | $0.2722 | $0.2767 | $0.262 | $0.2621 | 404.77K |
| Aug 26, 2026 | $0.274 | $0.285 | $0.262 | $0.2643 | 399.19K |
| Aug 25, 2026 | $0.288 | $0.288 | $0.2659 | $0.2661 | 350.57K |
| Aug 24, 2026 | $0.2848 | $0.3099 | $0.2716 | $0.2716 | 470.06K |
| Aug 21, 2026 | $0.293 | $0.3074 | $0.2788 | $0.281 | 466.71K |
| Aug 20, 2026 | $0.3076 | $0.317 | $0.287 | $0.2924 | 589.62K |
| Aug 19, 2026 | $0.3148 | $0.3285 | $0.2948 | $0.2948 | 1.4M |
| Aug 18, 2026 | $0.325 | $0.3314 | $0.31 | $0.315 | 591.96K |
| Aug 17, 2026 | $0.28 | $0.3387 | $0.2751 | $0.3266 | 1.15M |
| Aug 14, 2026 | $0.2631 | $0.2848 | $0.2631 | $0.2782 | 715.58K |
| Aug 13, 2026 | $0.2848 | $0.30 | $0.2728 | $0.2755 | 897.02K |
| Aug 12, 2026 | $0.2808 | $0.3015 | $0.2731 | $0.28 | 1.04M |
The latest Smart Investors Daily articles mentioning ARAY.
ARAY research
Company profile and research snapshot.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| May 12, 2026 | Jefferies | Hold | — |
| May 7, 2026 | BTIG | Neutral | — |
| Feb 5, 2026 | BTIG | Buy | — |
| Nov 6, 2025 | BTIG | Buy | — |
| Aug 14, 2025 | BTIG | Buy | — |
No generated briefing is available yet.
Yahoo · Aug 28, 2026
On August 19, Accuray Incorporated (NASDAQ:ARAY) held its fiscal fourth-quarter and full-year 2026 earnings call, laying out a business caught between a genuine financial rescue and a China market that is still bleeding revenue. Total net revenue fell 21% in the quarter to $100.9 million, and the company won’t even offer a forecast for the […]
Benzinga · Aug 27, 2026
Gainers Aethlon Medical (NASDAQ:AEMD) stock rose 50.7% to $3.27 during Thursday's after-market session. The market value of their outstanding shares is at $1.6 million. Modular Medical (NASDAQ:MODD) stock rose
SeekingAlpha · Aug 20, 2026
2026-08-20. The following slide deck was published by Accuray Incorporated in conjunction with their 2026 Q4 earnings call.
SeekingAlpha · Aug 19, 2026
Accuray Incorporated (ARAY) Q4 2026 Earnings Call August 19, 2026 4:30 PM EDTCompany ParticipantsStephen Monroe - Vice President of Financial Planning &...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning ARAY.
